These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 9550488

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antimalarial therapy in SLE.
    Lanham JG, Hughes GR.
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract] [Full Text] [Related]

  • 3. Keratopathy with low dose chloroquine therapy.
    Cullen AP, Chou BR.
    J Am Optom Assoc; 1986 May; 57(5):368-72. PubMed ID: 3711574
    [Abstract] [Full Text] [Related]

  • 4. [Eye toxicity of antimalarial agents].
    Graña Gil J, Cabana Vázquez M, Vázquez González A, Sánchez Meizoso MO.
    An Med Interna; 2002 Apr; 19(4):189-91. PubMed ID: 12090061
    [Abstract] [Full Text] [Related]

  • 5. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A, West B.
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Chloroquine and hydroxychloroquine dosage in juvenile rheumatoid arthritis].
    Laaksonen AL, Koskiahde V, Juva K.
    Duodecim; 1974 Oct; 90(2):125-31. PubMed ID: 4848261
    [No Abstract] [Full Text] [Related]

  • 8. Antimalarial drugs in pregnancy--the North American experience.
    Parke AL, Rothfield NF.
    Lupus; 1996 Jun; 5 Suppl 1():S67-9. PubMed ID: 8803915
    [Abstract] [Full Text] [Related]

  • 9. Antimalarial agents and lupus.
    Wallace DJ.
    Rheum Dis Clin North Am; 1994 Feb; 20(1):243-63. PubMed ID: 8153401
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A, Gaifullina R, Tigges C, Kirschke J, Altmeyer P, Gambichler T.
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [Abstract] [Full Text] [Related]

  • 12. [Antimalarial's retinopaty remains a current threat].
    Chiffoleau A, Guillet A, Zanlonghi X, Jolliet P.
    Presse Med; 2009 Apr; 38(4):662-3. PubMed ID: 19135848
    [No Abstract] [Full Text] [Related]

  • 13. Discontinuation of antimalarial drugs in systemic lupus erythematosus.
    Wang C, Fortin PR, Li Y, Panaritis T, Gans M, Esdaile JM.
    J Rheumatol; 1999 Apr; 26(4):808-15. PubMed ID: 10229401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recent findings about antimalarials in cutaneous lupus erythematosus: What dermatologists should know.
    Teboul A, Arnaud L, Chasset F.
    J Dermatol; 2024 Jul; 51(7):895-903. PubMed ID: 38482997
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus--a case report.
    Bogaczewicz J, Sobów T, Bogaczewicz A, Robak E, Bienkowski P, Sysa-Jedrzejowska A, Wozniacka A.
    Lupus; 2014 Feb; 23(2):188-93. PubMed ID: 24297641
    [Abstract] [Full Text] [Related]

  • 20. Current practice in antimalarial drug prescribing in rheumatoid arthritis.
    Bellamy N, Brooks PM.
    J Rheumatol; 1986 Jun; 13(3):551-5. PubMed ID: 3735276
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.